September 16, 2014
FDA approves MOVANTIK™ (naloxegol) Tablets C-II for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain
September 26, 2014
MOVENTIG® (naloxegol) Receives Positive CHMP Opinion in the European Union for the Treatment of Adults with Opioid-Induced Constipation
  



News Headlines
November 24 FDA Grants QIDP Designation to Bayer's Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation »
Events Calendar
November 6, 2014 Q3 2014 Financial Results Call
5:00 p.m. ET / 2:00 p.m. PT
Listen to this webcast
November 19-20, 2014 Jefferies Global Healthcare Conference
London, England
November 24, 2014 Brean Capital Life Sciences Summit
New York, NY
Media Highlights
Drug Discovery News:
Nektar makes progress against glioma
MIT Technology Review:
Opioids without Addiction
Nektar's Media Site
Broadcast Video
Image Gallery
Follow Us On Twitter
 
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide